Subcutaneous versus intravenous infliximab therapy – a real-world study: toward higher drug concentrations

Switching from IV-IFX to SC-IFX in IBD patients in clinical remission is effective and leads to higher infliximab serum concentrations, regardless of the combination with immunomodulatory therapy.

Authors

Sofıa Xavier (ORCID: https://orcid.org/0000-0001-6214-0584)
Ana Isabel Ferreira
Cátia Arieira (ORCID: https://orcid.org/0000-0001-7381-5532)
José Cotter (ORCID: https://orcid.org/0000-0002-2921-0648)
Tiago Lima Capela (ORCID: https://orcid.org/0000-0002-8010-4410)

Institutions

Hospital da Senhora da Oliveira Guimarães (PT)
University of Minho (PT)

Publication Details

Journal: European Journal of Gastroenterology & Hepatology
Published: 2024-08-19
DOI: https://doi.org/10.1097/meg.0000000000002835
Citations: 2
Primary Topic: Inflammatory Bowel Disease
Type: article
Field-Weighted Citation Impact: 1.10

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Subcutaneous versus intravenous infliximab therapy – a real-world study: toward higher drug concentrations

Sofıa Xavier, Ana Isabel Ferreira, Cátia Arieira, José Cotter et al.

Aug 19, 2024

2 citations

European Journal of Gastroenterology & Hepatology

Inflammatory Bowel Disease

1.10

article

Subcutaneous versus intravenous infliximab therapy – a real-world study: toward higher drug concentrations

Sofıa Xavier, Ana Isabel Ferreira, Cátia Arieira, José Cotter, Tiago Lima Capela

August 19, 2024article en

2 citations

Abstract

Switching from IV-IFX to SC-IFX in IBD patients in clinical remission is effective and leads to higher infliximab serum concentrations, regardless of the combination with immunomodulatory therapy.

European Journal of Gastroenterology & HepatologyVol. 36(11)

Hospital da Senhora da Oliveira Guimarães (PT), University of Minho (PT)

Good health and well-being

Openalex Percentile: Top 19%

Inflammatory Bowel Disease

1.10

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Subcutaneous versus intravenous infliximab therapy – a real-world study: toward higher drug concentrations — Sofıa Xavier, Ana Isabel Ferreira, et al. · European Journal of Gastroenterology & Hepatology (2024) | TGRS Research Map | TGRS